2010
Changes in Gleason Scores for Prostate Cancer
Ramos J, Uchio E, Aslan M, Concato J. Changes in Gleason Scores for Prostate Cancer. Journal Of Investigative Medicine 2010, 58: 625. DOI: 10.2310/jim.0b013e3181d4720c.Peer-Reviewed Original ResearchProstate Cancer, Comorbidity, and Participation in Randomized Controlled Trials of Therapy
Chao H, Mayer T, Concato J, Rose M, Uchio E, Kelly K. Prostate Cancer, Comorbidity, and Participation in Randomized Controlled Trials of Therapy. Journal Of Investigative Medicine 2010, 58: 566. DOI: 10.2310/jim.0b013e3181cf9002.Peer-Reviewed Original ResearchCastrate-resistant prostate cancerPhase 3 RCTsProstate cancerClinical settingPhase 3 clinical trialsVeterans Affairs Connecticut Healthcare SystemGeneral oncology practiceAbnormal laboratory valuesPopulation of patientsRandomized Controlled TrialsComplete medical recordsSerious medical conditionProportion of menBackground RandomizedChemotherapy regimensCRPC patientsControlled TrialsMedical recordsClinical trialsOncology practiceInclusion criteriaLaboratory valuesCardiac diseaseMedical conditionsClinical care
2006
The Effectiveness of Screening for Prostate Cancer: A Nested Case-Control Study
Concato J, Wells CK, Horwitz RI, Penson D, Fincke G, Berlowitz DR, Froehlich G, Blake D, Vickers MA, Gehr GA, Raheb NH, Sullivan G, Peduzzi P. The Effectiveness of Screening for Prostate Cancer: A Nested Case-Control Study. JAMA Internal Medicine 2006, 166: 38-43. PMID: 16401808, DOI: 10.1001/archinte.166.1.38.Peer-Reviewed Original ResearchConceptsDigital rectal examinationCase-control studyCause-specific mortalityCase patientsProstate cancerControl patientsNested Case-Control StudyProstate-specific antigen (PSA) testVeterans Affairs Medical CenterAssociation of screeningBenefits of screeningEffectiveness of screeningVeterans Affairs facilitiesVerbal informed consentEffectiveness of PSADRE screeningCause mortalityPSA testingSurvival benefitRectal examinationAntigen testMedical CenterAmbulatory carePatientsClinical practice
2002
What is “biochemical failure” in prostate cancer?
Lagu T, Wells C, Penson D, Concato J. What is “biochemical failure” in prostate cancer? Journal Of Clinical Epidemiology 2002, 55: 631. DOI: 10.1016/s0895-4356(02)00425-0.Peer-Reviewed Original ResearchProstate-specific antigenPSA failureMedian timeType of treatmentPSA slopeProstate cancerPost-treatment prostate-specific antigenVeterans Affairs Healthcare SystemAge-matched menProportion of menBiochemical failureSurgical failureTreatment failureSurrogate endpointsTherapeutic radiationAbility of providersVA sitesActual therapyPatientsClinical phenomenaCancerKappa statisticsHealthcare systemMenAmerican SocietyEffectiveness of screening for prostate cancer A nested case-control study
Concato J, Wells C, Penson D, Horwitz R, Peduzzi P. Effectiveness of screening for prostate cancer A nested case-control study. Journal Of Clinical Epidemiology 2002, 55: 630. DOI: 10.1016/s0895-4356(02)00422-5.Peer-Reviewed Original ResearchDigital rectal examProstate-specific antigenProstate cancerControl subjectsOdds ratioEffectiveness of PSAAssessment of ScreeningUnadjusted odds ratioCase-control studyVA Medical CenterYears of intakePotential screening testYears of ageCase-control designTime of deathYear of birthPSA testingImproved survivalRectal examMedical CenterAmbulatory careCase-control statusCase subjectsVA facilitiesScreening test
2001
A nested case–control study of the effectiveness of screening for prostate cancer research design
Concato J, Peduzzi P, Kamina A, Horwitz R. A nested case–control study of the effectiveness of screening for prostate cancer research design. Journal Of Clinical Epidemiology 2001, 54: 558-564. PMID: 11377115, DOI: 10.1016/s0895-4356(00)00355-3.Peer-Reviewed Original Research
2000
Treatment Decisions for Localized Prostate Cancer
Holmboe E, Concato J. Treatment Decisions for Localized Prostate Cancer. Journal Of General Internal Medicine 2000, 15: 694-701. PMID: 11089712, PMCID: PMC1495597, DOI: 10.1046/j.1525-1497.2000.90842.x.Peer-Reviewed Original ResearchConceptsExternal beam radiationLocalized prostate cancerWatchful waitingProstate cancerRadical prostatectomyTreatment optionsTreatment decisionsCommon reasonPattern of complicationsPrimary care providersRemoval of tumorsLack of evidencePhysician recommendationConsecutive menCare providersHigh riskPatient decisionCancerLonger durationPractice groupMenBeam radiationTreatmentPatientsShort duration
1997
What Is a Screening Test?; SGIM Headquarters Change of Address
Concato J. What Is a Screening Test?; SGIM Headquarters Change of Address. Journal Of General Internal Medicine 1997, 12: 607-612. PMID: 9346456, PMCID: PMC1497171, DOI: 10.1046/j.1525-1497.1997.07120.x.Peer-Reviewed Original ResearchConceptsDigital rectal examinationCase-control studyOdds ratioObservational studyClinical distinctionCase controlWest Haven Veterans Affairs Medical CenterVeterans Affairs Medical CenterFrequency of screeningProportion of subjectsPrevalence of cancerDiagnosis of cancerPatient's symptomsRectal examinationProstate cancerMedical CenterCase subjectsScreening testCancerScreeningSubjectsSymptomsPrevalenceDiagnosisStudy